Clinical Trial Update: Pharmacokinetic (PK) Bioequivalence and Pharmacodynamics of Julphar Insulin R and Huminsulin® Normal [Phase 1]

View source ↗

Summary

Phase 1 PK and pharmacodynamics study comparing Julphar Insulin R with Huminsulin Normal to assess bioequivalence in people with diabetes; the study is complete…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus

Drugs mentioned

• Huminsulin Normal (insulin)
• Julphar Insulin R (regular human insulin)

Snippet

Sponsor: Julphar Gulf Pharmaceutical Industries | Conditions: Diabetes Mellitus | Phase 1 | Status: COMPLETED